{
    "data": [
        {
            "id": "50929",
            "type": "article",
            "attributes": {
                "publishOn": "2007-10-23T07:40:58-04:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Retail Investors Should Grasp Opportunity In Vertex Pharmaceuticals",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "20678",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "84669",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1102",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/50929-retail-investors-should-grasp-opportunity-in-vertex-pharmaceuticals"
            }
        },
        {
            "id": "36899",
            "type": "article",
            "attributes": {
                "publishOn": "2007-05-31T02:07:28-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Vertex Pharmaceutical's Hepatitis Drug Proves Effective, But Path To Market Unclear",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "20678",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "83876",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1102",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/36899-vertex-pharmaceuticals-hepatitis-drug-proves-effective-but-path-to-market-unclear"
            }
        },
        {
            "id": "26698",
            "type": "article",
            "attributes": {
                "publishOn": "2007-02-12T03:49:27-05:00",
                "isLockedPro": false,
                "commentCount": 1,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Vertex Optimistic on Hepatitis C Drug",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "20123",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1102",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/26698-vertex-optimistic-on-hepatitis-c-drug"
            }
        },
        {
            "id": "23386",
            "type": "article",
            "attributes": {
                "publishOn": "2007-01-04T13:37:58-05:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Vertex Hepititis C Drug: A Potential Blockbuster",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "20325",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "83059",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1102",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/23386-vertex-hepititis-c-drug-a-potential-blockbuster"
            }
        }
    ]
}